Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUCCESS-B: Adjuvant Taxane-Based Chemotherapy in Early HER2+ Breast Cancer
NCT00670878Phase 3Completed
- Sponsor
- Ludwig Maximilian University of Munich
- Start
- Jun 2008
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine in breast cancer, sponsored by Ludwig Maximilian University of Munich. Started Jun 2008; status: completed.
02
Drugs
gemcitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00670878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00670878.